共 50 条
- [21] Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer - The Movsas article reviewed [J]. ONCOLOGY-NEW YORK, 2002, 16 (01): : 105 - 106
- [22] Treatment of elderly patients with non-small-cell lung cancer [J]. ONCOLOGY-NEW YORK, 2001, 15 (03): : 46 - 51
- [23] Elderly patients treatment with non-small-cell lung cancer [J]. ONCOLOGY IN CLINICAL PRACTICE, 2012, 8 (01): : 29 - 35
- [24] Treatment of advanced non-small-cell lung cancer in the elderly [J]. LUNG CANCER, 2009, 66 (03) : 282 - 286
- [25] The role of surgery in stage III non-small-cell lung cancer [J]. ONCOLOGY-NEW YORK, 2008, 22 (05): : 557 - 559
- [26] Gefitinib maintenance in stage III non-small-cell lung cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) : 4849 - 4850
- [27] Immunotherapy for Unresectable Stage III Non-Small-Cell Lung Cancer [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1986 - 1988
- [28] Multimodality therapy for stage III non-small-cell lung cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) : 3257 - 3269
- [29] Prognostic factors in stage III non-small-cell lung cancer [J]. CLINICAL LUNG CANCER, 2007, 8 (08) : 478 - 482